These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10624549)
21. Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia. McCormick SE; Stoessl AJ Neuroscience; 2002; 112(4):851-9. PubMed ID: 12088744 [TBL] [Abstract][Full Text] [Related]
27. Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia. Bhattachary SK; Bhattacharya D; Muruganandam AV Indian J Exp Biol; 2000 Sep; 38(9):945-7. PubMed ID: 12561957 [TBL] [Abstract][Full Text] [Related]
28. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide. Burger M; Fachinetto R; Calegari L; Paixão MW; Braga AL; Rocha JB Brain Res Bull; 2004 Dec; 64(4):339-45. PubMed ID: 15561469 [TBL] [Abstract][Full Text] [Related]
29. Study on the suitability of a rat model for tardive dyskinesia and the preventive effects of various drugs. Takeuchi H; Ishigooka J; Kobayashi K; Watanabe S; Miura S Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):679-91. PubMed ID: 9682280 [TBL] [Abstract][Full Text] [Related]
30. A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia. Goff DC; Renshaw PF; Sarid-Segal O; Dreyfuss DA; Amico ET; Ciraulo DA Biol Psychiatry; 1993 May; 33(10):700-6. PubMed ID: 8102552 [TBL] [Abstract][Full Text] [Related]
31. Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E. Elkashef AM; Wyatt RJ Schizophr Bull; 1999; 25(4):731-40. PubMed ID: 10667743 [TBL] [Abstract][Full Text] [Related]
32. Harpagophytum Procumbens Ethyl Acetate Fraction Reduces Fluphenazine-Induced Vacuous Chewing Movements and Oxidative Stress in Rat Brain. Schaffer LF; de Freitas CM; Chiapinotto Ceretta AP; Peroza LR; de Moraes Reis E; Krum BN; Busanello A; Boligon AA; Sudati JH; Fachinetto R; Wagner C Neurochem Res; 2016 May; 41(5):1170-84. PubMed ID: 26732278 [TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation. Datta S; Jamwal S; Deshmukh R; Kumar P Eur J Pharmacol; 2016 Jan; 771():229-35. PubMed ID: 26712377 [TBL] [Abstract][Full Text] [Related]
34. Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine. Busanello A; Leal CQ; Peroza LR; Röpke J; de Moraes Reis E; de Freitas CM; Libardoni M; de Vargas Barbosa NB; Fachinetto R Neurochem Res; 2017 Nov; 42(11):3033-3040. PubMed ID: 28744755 [TBL] [Abstract][Full Text] [Related]
36. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862 [TBL] [Abstract][Full Text] [Related]
37. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Waddington JL; Cross AJ; Gamble SJ; Bourne RC Science; 1983 Apr; 220(4596):530-2. PubMed ID: 6132447 [TBL] [Abstract][Full Text] [Related]
38. Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation. An HM; Tan YL; Shi J; Wang Z; Lv MH; Soares JC; Zhou D; Yang F; Zhang XY Phytomedicine; 2016 Dec; 23(13):1653-1660. PubMed ID: 27823630 [TBL] [Abstract][Full Text] [Related]
39. Tardive dyskinesia in outpatients on depot phenothiazine. Neehall J West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166 [TBL] [Abstract][Full Text] [Related]
40. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia. Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]